1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-30.29%
Both companies show declining cash positions (-30.29% vs CRON.TO's -0.43%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
-9.13%
Both CRON.TO and the company show zero Short-Term Investments Growth.
-10.50%
Cash + STI yoy ≥ 1.5x CRON.TO's -0.41%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
-37.18%
Receivables growth less than half of CRON.TO's 23.99%. David Dodd might see more conservative credit practices, provided revenue isn't suffering.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.91%
Below half of CRON.TO's 0.93%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.91%
Below half of CRON.TO's 1.85%. Michael Burry sees a potential red flag for stagnation or capital shortage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-50.64%
50-75% of CRON.TO's -76.92%. Bruce Berkowitz notes a more controlled liability line.
-50.64%
Less than half of CRON.TO's 13.81%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-50.64%
Less than half of CRON.TO's 15.26%. David Dodd sees far fewer liability expansions relative to competitor.
No Data
No Data available this quarter, please select a different quarter.
-7.97%
Similar yoy to CRON.TO's -8.57%. Walter Schloss sees parallel earnings retention vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-2.97%
Higher Other Stockholders' Equity Items Growth compared to CRON.TO's zero value, indicating worse performance.
-7.01%
Below half CRON.TO's 1.49%. Michael Burry sees potential underperformance in building shareholder capital.
-10.91%
Below half CRON.TO's 1.85%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
-9.13%
≥ 1.5x CRON.TO's -1.18%. David Dodd sees far stronger investment expansions than competitor.
No Data
No Data available this quarter, please select a different quarter.
30.29%
Above 1.5x CRON.TO's 0.45%. Michael Burry sees a major gap in net debt growth. Check coverage and liquidity.
